Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1961-1970 of 2922 for cancer

Edit search filters
  1. A Study To Assess Adverse Events And Change In Disease Activity In Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone Or With Standard Of Care In Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer And No Radiographic Evidence Of Disease

    Jacksonville, FL, Rochester, MN

  2. Long-term Outcomes of May-Thurner Syndrome in Pediatric Patients

    Rochester, MN

  3. Validation Of A Flow-micro Immunomagnetic System For Rare Cell Isolation From Peripheral Blood

    Rochester, MN

  4. A Study To Evaluate The Effectiveness And Safety Of CAEL-101 In Patients With Mayo Stage IIIa AL Amyloidosis

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Study Of Encorafenib + Cetuximab Plus Or Minus Binimetinib Vs. Irinotecan/Cetuximab Or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With A Safety Lead-in Of Encorafenib + Binimetinib + Cetuximab In Patients With BRAF V600E-mutant Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. 24-Week Study To Assess The PD, Safety, Tolerability, And PK Of GLM101 In Adults With PMM2-CDG

    Rochester, MN

  7. A Phase 2, Multi-center, Open-label Study To Evaluate The Efficacy And Safety Of Luspatercept (ACE-536) In Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis And Anemia With And Without Red Blood Cell-Transfusion Dependence

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  8. A Study Of Caplacizumab In Patients With Acquired Thrombotic Thrombocytopenic Purpura

    Rochester, MN

  9. The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies

    Scottsdale/Phoenix, AZ

  10. A Study To Assess The Safety And Pharmacokinetics Of GDC-8264 In Combination With Standard Of Care In Participants With Acute Graft-Versus-Host Disease (AGVHD)

    Rochester, MN

.

Mayo Clinic Footer